Canoe Financial LP Purchases 2,117 Shares of Cigna Group $CI

Canoe Financial LP raised its position in shares of Cigna Group (NYSE:CI) by 39.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 7,550 shares of the health services provider’s stock after buying an additional 2,117 shares during the quarter. Canoe Financial LP’s holdings in Cigna Group were worth $2,078,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Chesley Taft & Associates LLC raised its stake in Cigna Group by 3.5% during the fourth quarter. Chesley Taft & Associates LLC now owns 8,709 shares of the health services provider’s stock valued at $2,397,000 after buying an additional 297 shares during the last quarter. Woodward Diversified Capital LLC increased its holdings in shares of Cigna Group by 19.1% during the fourth quarter. Woodward Diversified Capital LLC now owns 1,302 shares of the health services provider’s stock valued at $358,000 after acquiring an additional 209 shares in the last quarter. Nepsis Inc. raised its holdings in Cigna Group by 10.4% in the fourth quarter. Nepsis Inc. now owns 42,886 shares of the health services provider’s stock worth $11,804,000 after buying an additional 4,046 shares during the last quarter. Exchange Traded Concepts LLC raised its holdings in Cigna Group by 31.7% in the 4th quarter. Exchange Traded Concepts LLC now owns 8,539 shares of the health services provider’s stock worth $2,350,000 after acquiring an additional 2,055 shares during the last quarter. Finally, Pallas Capital Advisors LLC raised its stake in shares of Cigna Group by 133.1% in the fourth quarter. Pallas Capital Advisors LLC now owns 4,774 shares of the health services provider’s stock worth $1,314,000 after purchasing an additional 2,726 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Analysts Set New Price Targets

CI has been the subject of a number of research analyst reports. Truist Financial lifted their price target on shares of Cigna Group from $320.00 to $350.00 and gave the stock a “buy” rating in a research note on Tuesday, February 17th. Sanford C. Bernstein raised Cigna Group from a “market perform” rating to an “outperform” rating and increased their price target for the company from $307.00 to $358.00 in a report on Thursday, March 12th. TD Cowen raised their price target on Cigna Group from $333.00 to $338.00 and gave the stock a “buy” rating in a research note on Monday, February 9th. Deutsche Bank Aktiengesellschaft upped their price objective on Cigna Group from $301.00 to $304.00 and gave the company a “buy” rating in a research report on Tuesday, February 10th. Finally, Leerink Partners increased their target price on Cigna Group from $270.00 to $297.00 and gave the company a “market perform” rating in a report on Friday, February 6th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $333.11.

Insider Activity

In other news, insider Everett Neville sold 1,719 shares of Cigna Group stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the transaction, the insider directly owned 5,670 shares of the company’s stock, valued at $1,638,119.70. The trade was a 23.26% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Nicole S. Jones sold 2,307 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the transaction, the insider owned 32,647 shares of the company’s stock, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.60% of the stock is owned by company insiders.

Cigna Group Stock Down 3.7%

CI opened at $261.98 on Friday. The firm’s 50 day simple moving average is $277.10 and its two-hundred day simple moving average is $280.31. The company has a market capitalization of $69.04 billion, a PE ratio of 11.81, a PEG ratio of 0.91 and a beta of 0.27. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.74.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. The firm had revenue of $72.50 billion during the quarter, compared to the consensus estimate of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The company’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, equities analysts forecast that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th were given a $1.56 dividend. The ex-dividend date was Thursday, March 5th. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. This represents a $6.24 dividend on an annualized basis and a yield of 2.4%. Cigna Group’s dividend payout ratio (DPR) is currently 28.13%.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.